CASE CCC IN THE NEWS
Cleveland Hospitals See Promise for Intraoperative Radiation Therapy in Breast Cancer Patients
The Plain Dealer - Jul 20, 2013
Intraoperative radiation therapy, or IORT, is a procedure in which a patient receives radiation immediately following surgery before leaving the operating room...Buoyed by encouraging data from its own recent study, the Cleveland Clinic this year has expanded its use of IORT in breast cancer patients. From November 2010 through December 2012, 78 breast cancer patients underwent IORT at the Clinic. More than 90 percent of patients had no recurrence of disease at the 12-month follow-up. The results of the study were published in April in the journal American College of Surgeons...
IORT also is available to patients as part of other studies, as well as to patients with a recurrence of breast cancer. Because the recurrence rate is so low in women who have had radiation in the past, there are only a handful of patients in that category in a year, said Dr. Janice Lyons, director of Breast Cancer Services at University Hospitals Case Medical Center and associate professor of radiation oncology at Case Western Reserve University School of Medicine.
New Radiation Therapy Prolongs Prostate Cancer Survival
New York Times - Jul 17, 2013
A new radiation therapy can extend the lives of men with the most advanced form of prostate cancer, a large new study has found...The drug's mechanism is not specific to prostate cancers. In clinical trials it has also shown promise in treating bone metastases resulting from breast cancer. And it is likely to help in treating bone metastases caused by other cancers as well, said Dr. Robert Dreicer, a prostate cancer specialist and the chairman of the Cleveland Clinic's department of solid tumor oncology, who was not involved in the new research.
Barbara Malone, Early-phase Cancer Clinical Trials Participant, Dies
The Plain Dealer - Jul 15, 2013
Funeral services for Barbara Malone, the Cleveland woman whose experience during and after her participation in a cancer clinical trial was documented by The Plain Dealer, will be Saturday...Dr. Smitha Krishnamurthi, Malone's oncologist at UH, on Monday called Malone's actions "very generous," adding that by sharing her story with the Plain Dealer, "She may have helped other patients to consider clinical trials."
FDA Approves Gilotrif for Late-stage NSCLC
Helio/HemOnc Today - Jul 12, 2013
Perspective by Nathan Pennell, MD, PhD. Patients with advanced non-small cell lung cancer whose tumors harbor mutations in the epidermal growth factor receptor (EGFR) gene – comprising about 10% of lung cancer cases – received good news when the FDA approved afatinib for first-line treatment in this population.
American Cancer Society Institutional Research Grant (IRG) Awards
The Case CCC, with funds from its American Cancer Society Institutional Research Grant, will provide seed money to foster cancer research by junior faculty who have no current national grant support of their own. Investigators in the CWRU School of Medicine and Cleveland Clinic Lerner College of Medicine as well as in other schools and colleges in the University are eligible. Grants, not to exceed $30,000, will be awarded to investigators who intend to gather preliminary data to be used in seeking future and independently funded programs.
IRG pilot project grants are intended to support independent, self-directed investigators early in their careers (assistant professor or equivalent). Applicants for the pilot project grants should be within six years of their first independent research or faculty appointment and eligible to apply for an independent national competitive research grant, but cannot currently hold such a grant. Recipients of IRG pilot project grants must be, at the time of the application, citizens or noncitizen nationals of the United States or its possessions and territories, or must have been lawfully admitted to the United States for permanent residence at the time of application.
LOI Deadline: August 12
Application Deadline: September 13